Join
Live feed
·
PRReleasevia Quantisnow
Autolus Therapeutics plc logo

Autolus Therapeutics to host virtual event to discuss the company's obe-cel program in systemic lupus erythematosus

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AUTL (Autolus Therapeutics plc) and more on Quantisnow.